Cytori Reports 2008 Results
Highlights for 2008 include the following: Launch of the Celution System into the cosmetic and reconstructive surgery market in Europe and Asia Pacific Initiation of a 70 patient
Amberstone Biosciences has signed a partnership and licence agreement with Shanghai Henlius Biotech for conditionally activated T-cell engager candidates to treat solid tumours.